Founder Directory
Built by Keitoto
Founders4
Known for these resultsRole25%Role is parsed from founder titles in yc.db. Known for 25% of these rows — the rest have no title at all, mostly 2019–2023. Those rows stay in the result and are counted as Unknown, never as No.Bio100%Bio coverage: 100% of these founders have a bio on their YC profile. Every bio-derived facet (ex-company, school, credentials, discipline) is Unknown for the rest.Ex-company25%Ex-company is matched from bios with employment context (ex-, formerly, worked at). 25% of these rows have at least one match.School0%School is matched from bios, case-sensitive for acronyms. 0% of these rows have at least one match.
- Pedro JaharaFounder · Lexter.aiW22B2B · São Paulo
- Roger Larach@rogerlarachFounder · R2W21Fintech · Mexico City
- Roger Teran@rogteranFounder · R2W21Fintech · Mexico City
- Artur Adib@r2rFounder/CEO · BiocognivS20Healthcare · Burlington
FOUNDERROLEBATCHINDUSTRYLOCATIONTEAMX_url
Pedro JaharaLexter.aiFounderWinter 2022B2BSão Paulo, Brazil18—Roger LarachR2FounderWinter 2021FintechMexico City, Mexico100https://x.com/rogerlarachRoger TeranR2FounderWinter 2021FintechMexico City, Mexico100https://x.com/rogteranArtur AdibBiocognivFounder/CEOSummer 2020HealthcareBurlington, United States6https://x.com/r2r
Showing 1–4 of 4 founders
Artur Adib
Founder/CEO·Biocogniv
PRIMARY INFO
RoleFounder/CEO
Team size6
BatchSummer 2020
LocationBurlington, United States
Company statusAcquired
StageEarly
BIO
Former faculty at the National Institutes of Health, PhD in computational physics. Founding team member and head of software at BETA Technologies (0-$2B in <5 years, IPO 2025), Twitter engineer (pre-IPO), and principal engineer at Magic Leap.
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
No notable employer or school mentioned in the bio.
CredentialsPhD
DisciplineResearcherKeyword match from the bio text, not a classifier.
TRACK RECORD
First YC company on record
COMPANY CONTEXT
Biocogniv
